Viral vectors: a look back and ahead on gene transfer technology

L Vannucci, M Lai, F Chiuppesi, L Ceccherini-Nelli… - New …, 2013 - arpi.unipi.it
No matter what their origin, strain and family, viruses have evolved exquisite strategies to
reach and penetrate specific target cells where they hijack the cellular machinery to express …

Naegleria fowleri: Sources of infection, pathophysiology, diagnosis, and management; a review

M Jahangeer, Z Mahmood, N Munir… - Clinical and …, 2020 - Wiley Online Library
Naegleria fowleri, a thermophilic flagellate amoeba known as a “brain‐eating” amoeba, is
the aetiological agent of a perilous and devastating waterborne disease known as primary …

Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR/Cas9-mediated gene editing

PI Ortinski, B O'Donovan, X Dong, B Kantor - Molecular therapy Methods & …, 2017 - cell.com
The CRISPR/Cas9 systems have revolutionized the field of genome editing by providing
unprecedented control over gene sequences and gene expression in many species …

[HTML][HTML] Vector-based genetically modified vaccines: Exploiting Jenner's legacy

B Ramezanpour, I Haan, A Osterhaus, E Claassen - Vaccine, 2016 - Elsevier
The global vaccine market is diverse while facing a plethora of novel developments. Genetic
modification (GM) techniques facilitate the design of'smarter'vaccines. For many of the major …

Non-invasive vaccines: challenges in formulation and vaccine adjuvants

S Han, P Lee, HJ Choi - Pharmaceutics, 2023 - mdpi.com
Given the limitations of conventional invasive vaccines, such as the requirement for a cold
chain system and trained personnel, needle-based injuries, and limited immunogenicity …

Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines

I del Moral-Sánchez, EG Wee, Y Xian, WH Lee… - npj Vaccines, 2024 - nature.com
Recombinant native-like HIV-1 envelope glycoprotein (Env) trimers are used in candidate
vaccines aimed at inducing broadly neutralizing antibodies. While state-of-the-art SOSIP or …

Integrase-defective lentiviral vector is an efficient vaccine platform for cancer immunotherapy

V Morante, M Borghi, I Farina, Z Michelini, F Grasso… - Viruses, 2021 - mdpi.com
Integrase-defective lentiviral vectors (IDLVs) have been used as a safe and efficient delivery
system in several immunization protocols in murine and non-human primate preclinical …

Integrase defective lentiviral vector as a vaccine platform for delivering influenza antigens

A Gallinaro, M Borghi, R Bona, F Grasso… - Frontiers in …, 2018 - frontiersin.org
Viral vectors represent an attractive technology for vaccine delivery. We exploited the
integrase defective lentiviral vector (IDLV) as a platform for delivering relevant antigens …

Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized …

M Borghi, A Gallinaro, MF Pirillo, A Canitano… - Frontiers in …, 2023 - frontiersin.org
Several COVID-19 vaccine strategies utilizing new formulations for the induction of
neutralizing antibodies (nAbs) and T cell immunity are still under evaluation in preclinical …

Parainfluenza virus 5 is a next‐generation vaccine vector for human infectious pathogens

T Wang, L Zheng, Q Zhao, Y Yao… - Journal of Medical …, 2023 - Wiley Online Library
Abstract Parainfluenza virus 5 (PIV5) is a negative‐sense, single‐stranded RNA virus that
can infect humans and many species of animals. Infection in these reservoir hosts is …